Clinical case of lung spindle cell carcinoma markedly responsive to pembrolizumab

A 52‐year‐old man underwent pneumonectomy of the left lung for previously diagnosed primary spindle cell carcinoma (pT4aN1M0, stage III B) with programmed death‐ligand 1 expression (tumor proportion score ≥95%) and without epidermal growth factor receptor gene mutation and anaplastic lymphoma kinase...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizushina, Yoshiko, Ohyanagi, Fumiyoshi, Shiihara, Jun, Nomura, Motoko, Ohta, Hiromitsu, Oshiro, Hisashi, Tsubochi, Hiroyoshi, Kusaka, Gen, Yamaguchi, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364993/
https://www.ncbi.nlm.nih.gov/pubmed/34227241
http://dx.doi.org/10.1111/1759-7714.14068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364993/
https://www.ncbi.nlm.nih.gov/pubmed/34227241
http://dx.doi.org/10.1111/1759-7714.14068

Ejemplares similares